CONTINUOUS INFUSION OF CHEMOTHERAPY ON AN OUTPATIENT BASIS VIA A TOTALLY IMPLANTED VENOUS ACCESS PORT

AG NANNINGA, EGE DEVRIES, PHB WILLEMSE, BE OOSTERHUIS, DT SLEIJFER, HJ HOEKSTRA, NH MULDER

    Research output: Contribution to journalArticleAcademicpeer-review

    21 Citations (Scopus)

    Abstract

    170 patients were treated with continuous infusion of epirubicin, mitoxantrone, carboplatin or 5-fluorouracil through an implanted venous access port with a portable infusion pump. A total of 440 cycles were given on an outpatient basis. The patients were instructed how to dissolve their drugs and to change the syringes. The complication rate was low. 10 patients developed a thrombosis of the subclavian vein, resulting in cessation of therapy in 5. Pulmonary embolism occurred twice, in 1 patient during a period of subclavian vein thrombosis. Needle dislocation occurred 6 times and catheter occlusion 20 times. Patency was restored with saline or urokinase. Local infection occurred 3 times and systemic infection only once. This technique is suitable for continuous infusion of different cytostatic drugs on an outpatient basis. Patients were able to prepare their drugs at home and the system can remain in situ for 3 weeks without increasing the complication rate.

    Original languageEnglish
    Pages (from-to)147-149
    Number of pages3
    JournalEuropean Journal of Cancer
    Volume27
    Issue number2
    Publication statusPublished - 1991

    Keywords

    • 21-DAY CONTINUOUS INFUSION
    • INTRAVENOUS CHEMOTHERAPY
    • PHASE-I
    • SYSTEM
    • EPIRUBICIN
    • SCHEDULE
    • CATHETER
    • CANCER

    Fingerprint

    Dive into the research topics of 'CONTINUOUS INFUSION OF CHEMOTHERAPY ON AN OUTPATIENT BASIS VIA A TOTALLY IMPLANTED VENOUS ACCESS PORT'. Together they form a unique fingerprint.

    Cite this